XML 63 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share-Based Compensation (Tables)
12 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-Based Compensation Plans Total share-based compensation included as a component of selling, general and administrative expenses in our Consolidated Income Statements was as follows:
 Fiscal Year Ended June 30,
 202420232022
 (in thousands)
Share-based compensation related to:
Equity classified stock options$550 $1,426 $1,848 
Equity classified restricted stock8,987 9,793 9,815 
Total share-based compensation$9,537 $11,219 $11,663 
Schedule of Stock Option Plans
A summary of activity under our stock option plans is presented below:

 Fiscal Year Ended June 30, 2024
 OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value
Outstanding, beginning of year1,026,671 $32.76 
Granted during the period— — 
Exercised during the period(195,073)24.72 
Canceled, forfeited, or expired during the period(119,646)42.15 
Outstanding, end of year711,952 33.38 3.47$7,784,250 
Vested and expected to vest at June 30, 2024711,952 33.38 3.47$7,784,250 
Exercisable, end of year711,952 $33.38 3.47$7,784,250 
Schedule of Unvested Shares
As of June 30, 2024 there were no unvested options as presented below:

 Fiscal Year Ended June 30, 2024
 OptionsWeighted Average Exercise PriceWeighted Average
Grant Date 
Fair Value
Unvested, beginning of year170,837 $25.12 $9.06 
Granted— — — 
Vested(51,191)25.14 9.08 
Canceled or forfeited(119,646)42.15 11.85 
Unvested, end of year— $— $— 
Schedule of Stock Options Outstanding The following table summarizes information about stock options outstanding and exercisable as of June 30, 2024:
 Options OutstandingOptions Exercisable
Range of Exercise PricesShares
  Outstanding
Weighted
Average
Remaining
  Contractual Life
Weighted Average
Exercise
Price
Number ExercisableWeighted Average
Exercise
Price
$22.27 - $26.38
168,920 6.3824.62 168,920 24.62 
$26.38 - $30.49
119,021 6.4027.14 119,021 27.14 
$30.49 - $34.60
53,079 3.4434.35 53,079 34.35 
$34.60 - $38.71
206,839 1.8237.72 206,839 37.72 
$38.71 - $42.82
164,093 0.4341.13 164,093 41.13 
711,952 3.47$33.38 711,952 $33.38 
Schedule of Restricted Stock Outstanding
During the fiscal year ended June 30, 2024, the Company granted 488,208 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs:
 Fiscal Year Ended June 30, 2024
 Shares
granted
Date grantedGrant date
fair value
Vesting period
Employees
Certain employees based on performance315,731 August 25, 2023$31.52 
Annually over 4 years
Certain employees based on performance64,532 August 25, 2023$35.15 
Annually over 3 years
Certain employees based on performance64,527 August 25, 2023$31.52 
Annually over 3 years
Certain employees based on performance1,507 September 1, 2023$33.20 
Annually over 4 years
Certain employees based on hire2,276 March 31, 2024$43.94 
Annually over 4 years
Certain employees based on hire1,563 June 3, 2024$48.01 
Annually over 4 years
Non-Employee Directors
Certain Directors38,072 August 25, 2023$31.52 
12 months

A summary of the status of the Company’s outstanding restricted stock is presented below:

 Fiscal Year Ended June 30, 2024
 SharesWeighted-Average
Grant Date Fair
Value
Outstanding, beginning of year889,910 $30.43 
Granted during the period488,208 32.12 
Vested during the period(273,134)28.63 
Cancelled, forfeited, or expired during the period(217,674)31.70 
Outstanding, end of year887,310 $31.73